Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is InSilico Medicine Cayman TopCo Days Payable?
InSilico Medicine Cayman TopCoISLMF -1.77%13 Days Payable is 185.60 as of Dec. 2025, which is 56% below its 10-year median of 418.02. GuruFocus rates ISLMF with a GF Score™ of 13/100. The stock has 3 warning signs investors should review. Among 2,608 Software companies, InSilico Medicine Cayman TopCo ranks better than 92.18% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Infrastructure subindustry, InSilico Medicine Cayman TopCo's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InSilico Medicine Cayman TopCo Days Payable vs Software Industry
For the Software industry and Technology sector, InSilico Medicine Cayman TopCo's Days Payable distribution charts can be found below:
* The bar in red indicates where InSilico Medicine Cayman TopCo's Days Payable falls into.
InSilico Medicine Cayman TopCo Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InSilico Medicine Cayman TopCo (ISLMF) has a Days Payable of 185.60 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on InSilico Medicine Cayman TopCo and its competitors. This is 56% below median its historical median of 418.02. Over the past decade, InSilico Medicine Cayman TopCo's Days Payable has ranged from 341.40 to 592.84. According to the industry distribution chart, InSilico Medicine Cayman TopCo ranks #204 out of 2608 companies in the Software industry, placing it in the top 7.8%.
Is InSilico Medicine Cayman TopCo's Days Payable too high?
InSilico Medicine Cayman TopCo's current Days Payable of 185.60 is 56% below median its 10-year median of 418.02. Over the past 10 years, this metric has ranged from a low of 341.40 to a high of 592.84. The Software industry median Days Payable is 51.82. InSilico Medicine Cayman TopCo's value of 185.60 is 258.2% above this industry median. Based on the distribution chart, InSilico Medicine Cayman TopCo ranks #204 out of 2608 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, InSilico Medicine Cayman TopCo has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does InSilico Medicine Cayman TopCo's Days Payable compare to ?
According to the Software industry distribution chart, InSilico Medicine Cayman TopCo ranks #204 out of 2608 companies for Days Payable. This places InSilico Medicine Cayman TopCo in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 51.82. InSilico Medicine Cayman TopCo's value of 185.60 is 258.2% above this benchmark. Historically, InSilico Medicine Cayman TopCo's own Days Payable has ranged from 341.40 to 592.84 over the past decade. While the company's 10-year median is 418.02 vs. the industry median of 51.82, InSilico Medicine Cayman TopCo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Software company?
The median Days Payable among Software companies is 51.82, based on 2,608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InSilico Medicine Cayman TopCo's current Days Payable of 185.60 is 258.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on InSilico Medicine Cayman TopCo and its competitors. For the Software industry, the median Days Payable is 51.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InSilico Medicine Cayman TopCo's current Days Payable is 185.60, which is 56% below median its own 10-year median of 418.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InSilico Medicine Cayman TopCo stock overvalued right now?
InSilico Medicine Cayman TopCo (ISLMF) has a current Days Payable of 185.60. The current Days Payable is 185.60, which is 56% below median its 10-year median of 418.02 and 258.2% above the Software industry median of 51.82. InSilico Medicine Cayman TopCo's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For InSilico Medicine Cayman TopCo (ISLMF), the current Days Payable is 185.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
InSilico Medicine Cayman TopCo is engaged in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. It has generated multiple clinical-stage or IND-enabling assets using Pharma.AI, an AI-enabled platform that supports drug discovery and development activities. The company operates under a project-based business model, deriving revenue from out-licensing and collaboration arrangements. Geographically, the company generates revenue from multiple countries, with the majority of the revenue coming from United States.
13GF Score
Get the complete analysis for ISLMF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISLMF has been successfully added to your 
